Dermira Leans On Patient Experience With Hyperhidrosis As It Readies For Qbrexza Launch

Chief Commercial Officer Lori Lyons-Williams tells Scrip that patient stories were the tipping point for many payers considering Qbrexza's $550 per month price. Dermira's also catering to patients with co-pay assistance and a commitment not to raise pricing until after 2019.